[Flag_This]

"The use of adult stem cells have come so far in the last ten years that the “need” for embryonic cells has dropped dramatically."

Nevertheless, a Market Watch article about this states: "ViaCyte's lead product candidate, the VC-01 combination product, is based on the production of pancreatic progenitor cells derived from human pluripotent stem cells." link

My youngest son has Type 1 diabetes, which, should this ever become an actual treatment, presents us with quite the moral dilemma.

[Vermont Lt]

As with anything in bio genetics, it changes every year or so.

Good luck. I appreciate your dilemma. A cure is coming.

[untenured]

I hear you. I've had it since 1980, and long ago decided I would have to say no to embryonic cell-based treatment.

Having said that, they've been talking about encapsulation for twenty years, so it would take more than this to get me excited anyway.